CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis

Figure 6

Association of CD147 expression with clinicopathological parameters. Notes. (a) The forest plot for the overall association between CD147 expression and tumor stage in patients with HCC. CD147 expression was not associated with tumor size of HCC cancer (OR = 0.38; 95% CI: 0.14–1.03; ). (b) The forest plot for the overall association between CD147 expression and cirrhosis in patients with HCC. CD147 expression was not associated with cirrhosis of HCC cancer (OR = 0.4; 95% CI: 0.13–1.45; ). (c) The forest plot for the overall association between CD147 expression and differentiation in patients with HCC. CD147 expression was not associated with differentiation of HCC cancer (OR = 0.54; 95% CI: 0.15–1.96; ). (d) The forest plot for the overall association between CD147 expression and TMN in patients with HCC. CD147 expression was associated with the TNM stage of HCC cancer (OR = 0.18; 95% CI: 0.04–0.85; ). (e) The forest plot for the overall association between CD147 expression and lymph node metastasis in patients with HCC. CD147 expression was not associated with lymph node metastasis of HCC cancer (OR = 3.60; 95% CI: 0.96–13.53; ). (f) The forest plot for the overall association between CD147 expression and HBsAg in patients with HCC. CD147 expression was not associated with HBsAg of HCC cancer (OR = 1.06; 95% CI: 0.64–1.74; ). (g) The forest plot for the overall association between CD147 expression and venous invasion in patients with HCC. CD147 expression was associated with venous invasion of HCC cancer (OR = 6.29; 95% CI: 1.70–23.20; ). (h) The forest plot for the overall association between CD147 expression and serum AFP level in patients with HCC. CD147 expression was not associated with serum AFP level of HCC cancer (OR = 0.28; 95% CI: 0.04–1.89; ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)